Brief: Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China

Cumberland Pharmaceuticals

15/05/2019 14:37

May 15 (Reuters) - Cumberland Pharmaceuticals Inc  CPIX.O :
    * CUMBERLAND PHARMACEUTICALS SIGNS EXCLUSIVE LICENSING
AGREEMENT
FOR DISTRIBUTION IN CHINA
    * CUMBERLAND PHARMACEUTICALS INC - AGREEMENT GIVES WINHEALTH
PHARMA GROUP EXCLUSIVE RIGHTS FOR ACETADOTE® AND CALDOLOR® IN
CHINA
    * CUMBERLAND PHARMACEUTICALS INC - WINHEALTH IS RESPONSIBLE
FOR
SEEKING REGULATORY APPROVAL FOR TWO INJECTABLE BRANDS IN CHINA
    * CUMBERLAND PHARMACEUTICALS INC - MAINTAINS RESPONSIBILITY
FOR
INTELLECTUAL PROPERTY, PRODUCT FORMULATION, DEVELOPMENT, AND
OTHER SUPPORTING ACTIVITIES
    * CUMBERLAND PHARMACEUTICALS - ENTERED INTO EXCLUSIVE
AGREEMENT
WITH CHINA'S WINHEALTH PHARMA GROUP FOR LICENSING RIGHTS OF
ACETADOTE INJECTION
    * CUMBERLAND PHARMACEUTICALS INC - CUMBERLAND WILL RECEIVE
UPFRONT
AND MILESTONE LICENSING PAYMENTS, AS WELL AS ROYALTIES ON FUTURE
SALES OF BOTH DRUGS.
    * CUMBERLAND PHARMACEUTICALS - ENTERED INTO EXCLUSIVE
AGREEMENT
WITH CHINA'S WINHEALTH PHARMA GROUP FOR LICENSING RIGHTS OF
CALDOLOR INJECTION

Source text for Eikon:  ID:nPnb77ksba 
Further company coverage:  CPIX.O 

 ((Briefs@thomsonreuters.com;))